A federal appeals court recently dismissed a case that could have saved consumers hundreds of millions of dollars. Solvay Pharmaceutical, the maker of a synthetic form of testosterone called Androgel, had...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: